Cipla launches inhalable insulin for diabetes care
New Delhi, Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country. The company had obtained regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) late last year for the exclusive distribution and marketing of Afrezza, a rapid-acting orally inhaled insulin, which offers a needle-free,…